| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &Immunovant CEO | President &COO | Chief Operating Officer
1 company
Venker Eric serves as a President &Immunovant CEO at ROIV. Across recent SEC filings that breaks down to 0 buys and 85 sells. Those positions are worth an estimated $58.5M at current prices.
Historically, Venker Eric's trades have earned a below-average insider score of 42/100 across 81 rated trades. Over a 12-month horizon, 16.1% of those trades were profitable, with an average 12-month return of -44.5%.
The biggest single holding is ROIV (~$58.5M) as President &Immunovant CEO. The recent filings there lean toward selling, a net 12,977,626 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 200,000 | $34.95 | $6,990,000.00 | -11.0% | - | - | |
| Jun 24, 2026 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 200,000 | $33.16 | $6,631,267.64 | -5.8% | - | - | |
| Apr 20, 2026 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 200,000 | $29.59 | $5,918,000.00 | -10.8% | +16.7% | - | |
| Jan 12, 2026 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 200,000 | $21.92 | $4,384,000.00 | -10.8% | +27.3% | - | |
| Dec 24, 2025 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 275,000 | $22.47 | $6,179,750.00 | -7.8% | +19.4% | - | |
| Dec 9, 2025 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 200,000 | $20.85 | $4,170,000.00 | -11.8% | +44.5% | - | |
| Nov 7, 2025 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 200,000 | $20.22 | $4,044,000.00 | -11.7% | +2.5% | - | |
| Oct 17, 2025 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 851,383 | $16.99 | $14,467,502.37 | -15.9% | +35.0% | - | |
| Oct 13, 2025 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 125,667 | $16.29 | $2,047,335.75 | -4.0% | +36.7% | - | |
| Oct 8, 2025 | ROIV Roivant Sciences Ltd. | President &Immunovant CEO | Sale+OE | 665,159 | $16.21 | $10,781,813.19 | -12.8% | +34.8% | - |